The Australian drug group was notified of two more deaths from blood clotting after receiving the AstraZeneca vaccine.
According to the Therapeutic Goods Department, these are the fifth and sixth deaths associated with the first dose of 6.1 million vaccines. Latest update..
The deaths of the two were associated with a confirmed case of blood coagulation, also known as thrombosis with thrombocytopenia syndrome (TTS).
One dead was a 44-year-old man from Tasmania and the other was a 48-year-old woman from Victoria. This follows the death of a 72-year-old woman in South Australia on July 11.
Tasmanian Premier Peter Gutwein and Health Minister Jeremy Rockliff have issued the following statement:
“The man died last weekend in a hospital he was being treated for. His family is seeking privacy on this issue, and with deep respect for them, it is not appropriate to provide further information at this time. There is none.”
The Tasmanian Government said it would continue to follow expert health advice on vaccination programs.
Ben Kaui, Deputy Chief Health Officer of Victoria, emphasized the low mortality rate of vaccines.
“That’s one millionth,” he told reporters on July 22. COVID-19 (new coronavirus infection. “
According to the TGA, the total number of TTS cases so far has been 87. The TGA also received 1,177 side effect reports between July 12th and 18th.
Australian officials advise that vaccinated individuals should see a doctor if they experience symptoms such as severe or persistent headaches, blurred vision, confusion, or seizures.
Meanwhile, the United Kingdom (UK) Recorded 71 deaths It is associated with blood clotting or low platelets after AstraZeneca vaccination and has fully vaccinated 36.5 million people.